These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30155665)

  • 1. Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review.
    Qiu O; Chan T; Luen M; Cruz JE; Hermes-DeSantis ER
    Rheumatol Int; 2018 Dec; 38(12):2209-2216. PubMed ID: 30155665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
    Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
    Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon.
    Curtiss P; Schwager Z; Cobos G; Lo Sicco K; Franks AG
    J Am Acad Dermatol; 2018 Jun; 78(6):1110-1118.e3. PubMed ID: 29408338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis.
    Anderson ME; Moore TL; Hollis S; Jayson MI; King TA; Herrick AL
    Rheumatology (Oxford); 2002 Mar; 41(3):324-8. PubMed ID: 11934971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon.
    Teh LS; Manning J; Moore T; Tully MP; O'Reilly D; Jayson MI
    Br J Rheumatol; 1995 Jul; 34(7):636-41. PubMed ID: 7670782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate.
    Hughes M; Moore T; Manning J; Wilkinson J; Dinsdale G; Roberts C; Murray A; Herrick AL
    Microvasc Res; 2017 May; 111():32-36. PubMed ID: 28027937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy: A local approach to Raynaud phenomenon.
    Herrick AL
    Nat Rev Rheumatol; 2009 May; 5(5):246-7. PubMed ID: 19412190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical nitroglycerin ointment in Raynaud's phenomenon.
    Fischer M; Reinhold B; Falck H; Török M; Alexander K
    Z Kardiol; 1985 May; 74(5):298-302. PubMed ID: 3925656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease.
    Franks AG
    Lancet; 1982 Jan; 1(8263):76-7. PubMed ID: 6119495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.
    Black CM; Halkier-Sørensen L; Belch JJ; Ullman S; Madhok R; Smit AJ; Banga JD; Watson HR
    Br J Rheumatol; 1998 Sep; 37(9):952-60. PubMed ID: 9783759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches?
    Pérez-Legaz J; Arroyo A; Moya P; Ruiz-Tovar J; Frangi A; Candela F; Oliver MI; Calpena R
    Dis Colon Rectum; 2012 Aug; 55(8):893-9. PubMed ID: 22810476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
    Herrick AL; van den Hoogen F; Gabrielli A; Tamimi N; Reid C; O'Connell D; Vázquez-Abad MD; Denton CP
    Arthritis Rheum; 2011 Mar; 63(3):775-82. PubMed ID: 21360507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local treatment of anal fissure with nitroglycerin ointment].
    Osterwald-Lenum NS; Rosenberg J; Bülow S
    Ugeskr Laeger; 1998 Aug; 160(36):5211-4. PubMed ID: 9741288
    [No Abstract]   [Full Text] [Related]  

  • 17. A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre.
    Gargh K; Baildam EM; Cleary GA; Beresford MW; McCann LJ
    Rheumatology (Oxford); 2010 Jan; 49(1):193-4. PubMed ID: 19797310
    [No Abstract]   [Full Text] [Related]  

  • 18. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon.
    Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM
    Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser Doppler imaging evaluation of nitroglycerin patch application in systemic sclerosis patients.
    Pintea Bentea G; Wauters A; Wautrecht JC; Cogan E
    Vasc Med; 2020 Dec; 25(6):559-568. PubMed ID: 32990196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's syndrome, 2011].
    Takáts A; Garai I; Papp G; Hevér T; Csiki E; András C; Csiki Z
    Orv Hetil; 2012 Mar; 153(11):403-9. PubMed ID: 22390864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.